Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection

被引:47
|
作者
Gyetko, MR
Sud, S
Chen, GH
Fuller, JA
Chensue, SW
Toews, GB
机构
[1] Ann Arbor Vet Affairs Med Ctr, Pulm & Crit Care Med Div, Dept Internal Med, Ann Arbor, MI 48105 USA
[2] Ann Arbor Vet Affairs Med Ctr, Pulm & Crit Care Med Div, Dept Pathol, Ann Arbor, MI 48105 USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 02期
关键词
D O I
10.4049/jimmunol.168.2.801
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Urokinase-type plasminogen activator (uPA)(-/-) mice cannot mount protective host defenses during infection with the opportunistic yeast Cryptococcus neoformaus (52D). Because effective host defense against C. neoformans requires specific immune responses and the generation of type 1 (T1) cytokines, we determined how the absence of uPA impacts these processes. Wild-type (WT) and uPA(-/-) mice were inoculated with C. neoformans. Macrophage antifungal activity was assessed histologically, T lymphocyte responses in vivo and proliferation in vitro were quantified, and cytokine concentrations were determined by ELISA. uPA(-/-) macrophages have impaired antimicrobial activity. Regional lymph nodes of infected uPA(-/-) mice contained fewer cells than WT, suggesting impaired T cell proliferation in response to the pathogen in vivo. In vitro, uPA(-/-) T lymphocytes had impaired proliferative responses to C. neoformans rechallenge compared with WT. Infected WT mice generated T1 cytokines in the lung, characterized by high levels of IFN-gamma and IL-12. uPA(-/-) mice had decreased levels of IFN-gamma and IL-12, and increased IL-5, a type 2 cytokine. In the absence of uPA, the cytokine profile of regional lymph nodes shifted from a T1 pattern characterized by IFN-gamma and IL-2 to a weak, nonpolarized response. We conclude that in the absence of uPA, lymphocyte proliferative responses are diminished, and mice fail to generate protective T1 cytokines, resulting in impaired antimicrobial activity. This study provides novel evidence that uPA is a critical modulator of immune responses and of immune cell effector functions in vivo.
引用
收藏
页码:801 / 809
页数:9
相关论文
共 50 条
  • [31] Identification of a novel inhibitor of urokinase-type plasminogen activator
    Zhu, Ming
    Gokhale, Vijay M.
    Szabo, Lajos
    Munoz, Ruben M.
    Baek, Hyounggee
    Bashyam, Sridevi
    Hurley, Laurence H.
    Von Hoff, Daniel D.
    Han, Haiyong
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (04) : 1348 - 1356
  • [32] Properties of the urokinase-type plasminogen activator modified with phenylglyoxal
    Moukhametova, LI
    Aisina, RB
    Lomakina, GY
    Varfolomeev, SD
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2002, 28 (04) : 278 - 283
  • [33] THE CHICKEN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE
    LESLIE, ND
    KESSLER, CA
    BELL, SM
    DEGEN, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (03) : 1339 - 1344
  • [34] Elucidating novel urokinase-type plasminogen activator inhibitors
    Smith, E.
    Spencer, J.
    Ali, M.
    Abdinejad, M.
    Kankanala, J.
    Fishwick, C.
    Philippou, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : E18 - E18
  • [35] A CELLULAR RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    BELIN, D
    BACCINO, D
    WOHLWEND, A
    ESTREICHER, A
    HUARTE, J
    VASSALLI, JD
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 46 - 46
  • [36] Elucidating novel urokinase-type plasminogen activator inhibitors
    Smith, E. L.
    John, S.
    Abdinejad, M.
    Kankanala, J.
    Fishwick, C. W. G.
    Philippou, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 819 - 819
  • [37] Urokinase-type plasminogen activator in carcinomatous pleural fluid
    Ishikawa, H
    Satoh, H
    Hasegawa, S
    Yazawa, T
    Naito, T
    Yamashita, YT
    Ohtsuka, M
    Ogata, T
    Kamma, H
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (07) : 1566 - 1571
  • [38] Urokinase-Type Plasminogen Activator Inhibits Efferocytosis of Neutrophils
    Yang, Yanping
    Friggeri, Arnaud
    Banerjee, Sami
    Bdeir, Khalil
    Cines, Douglas B.
    Liu, Gang
    Abraham, Edward
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (12) : 1516 - 1523
  • [39] Properties of the Urokinase-Type Plasminogen Activator Modified with Phenylglyoxal
    L. I. Moukhametova
    R. B. Aisina
    G. Yu. Lomakina
    S. D. Varfolomeev
    Russian Journal of Bioorganic Chemistry, 2002, 28 : 278 - 283
  • [40] Urokinase-type plasminogen activator in human gliomas in vitro
    Gillespie, J
    McCormick, D
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1996, 22 (05) : 454 - 454